ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves

Tuesday, July 8, 2014

Submitted by

Ruben Osnabrugge

Source

Source Name: Journal of the American Medical Association

Source URL: http://jama.jamanetwork.com/article.aspx?articleID=1886189&utm_source=Silverchai…

Author(s)

Danny Dvir; John G. Webb; Sabine Bleiziffer; Miralem Pasic; Ron Waksman; Susheel Kodali; Marco Barbanti; Azeem Latib; Ulrich Schaefer; Josep Rodés-Cabau; Hendrik Treede; Nicolo Piazza; David Hildick-Smith; Dominique Himbert; Thomas Walther; Christian Hengstenberg; Henrik Nissen; Raffi Bekeredjian; Patrizia Presbitero;Enrico Ferrari; Amit Segev; Arend de Weger; Stephan Windecker; Neil E. Moat; Massimo Napodano; Manuel Wilbring;Alfredo G. Cerillo; Stephen Brecker; Didier Tchetche; Thierry Lefèvre; Federico De Marco, MD; Claudia Fiorina, MD;Anna Sonia Petronio; Rui C. Teles; Luca Testa; Jean-Claude Laborde; Martin B. Leon; Ran Kornowski

The consortium of authors of this paper determined the survival after Transcatheter valve in valve implantation inside a failed surgical bioprosthesis. The authors report a 1 month mortality rate of 7.6% and a major stroke rate of 1.7%. One-year survival was 83.2%, and 313 (92.6%) of survivors had a good functional status (NYHA I/II). Patients who had an aortic stenosis (n=181) had worse 1-year survival (76.6%) than patients with aortic regurgitation (91.2%) or combined stenosis/regurgigation (83.9%; p=0.01). Moreover, a small surgical bioprosthesis was associated with higher mortality.